Medically reviewed by Marla Anderson, MD Uterine cancer occurs when cells in the uterus (an organ in the pelvis of people ...

15% to 20% of people with early-stage (stage I or II) endometrial cancer will have a recurrence. Around 50% of them have a local recurrence, 25% have a distant recurrence, and 25% have both local ...

Metastatic endometrial cancer is when cancer that starts in the lining of the uterus (endometrium) spreads to other parts of the body. Your doctor may call it stage IV endometrial cancer or ...

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

The following is a summary of “Disparities in clinical drug trial participation in endometrial cancer: a real-world analysis, ...

In this video, Robert DeBernardo, MD, discusses the prognostic potential of molecular profiling to treat endometrial cancer, a topic presented at Society of Gynecologic Oncology Annual Meeting on ...

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient (dMMR), surgically resectable endometrial cancer, according to findings presented at the SGO 2025 Annual ...

Further, we are obliged to ask what is the relevance of these data in a world where the treatment paradigm for endometrial cancer has evolved? Many patients with advanced-stage or recurrent ...